Proper functioning of all organs, including the brain, requires iron. It is present in different forms in biological fluids, and alterations in its distribution can induce oxidative stress and neurodegeneration. However, the clinical parameters normally used for monitoring iron concentration in biological fluids (i.e., serum and cerebrospinal fluid) can hardly detect the quantity of circulating iron, while indirect measurements, e.g., magnetic resonance imaging, require further validation. This review summarizes the mechanisms involved in brain iron metabolism, homeostasis, and iron imbalance caused by alterations detectable by standard and non-standard indicators of iron status. These indicators for iron transport, storage, and metabolism can help to understand which biomarkers can better detect iron imbalances responsible for neurodegenerative diseases.

Alteration of iron concentration in alzheimer’s disease as a possible diagnostic biomarker unveiling ferroptosis

Ficiarà E.
;
Munir Z.;Boschi S.;Guiot C.
2021

Abstract

Proper functioning of all organs, including the brain, requires iron. It is present in different forms in biological fluids, and alterations in its distribution can induce oxidative stress and neurodegeneration. However, the clinical parameters normally used for monitoring iron concentration in biological fluids (i.e., serum and cerebrospinal fluid) can hardly detect the quantity of circulating iron, while indirect measurements, e.g., magnetic resonance imaging, require further validation. This review summarizes the mechanisms involved in brain iron metabolism, homeostasis, and iron imbalance caused by alterations detectable by standard and non-standard indicators of iron status. These indicators for iron transport, storage, and metabolism can help to understand which biomarkers can better detect iron imbalances responsible for neurodegenerative diseases.
22
9
4479
4504
Alzheimer’s disease; Biomarkers; Ferroptosis; Iron; Neurodegeneration; Alzheimer Disease; Biomarkers; Brain; Ceruloplasmin; Ferritins; Ferroptosis; Humans; Iron; Iron Metabolism Disorders; Magnetic Resonance Imaging; Neurodegenerative Diseases; Oxidative Stress; Transferrin
Ficiarà E.; Munir Z.; Boschi S.; Caligiuri M.E.; Guiot C.
File in questo prodotto:
File Dimensione Formato  
ijms-22-04479-v2.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 2.39 MB
Formato Adobe PDF
2.39 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1795052
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact